Acute myocardial infarction in Alberta: Temporal changes in outcomes, 1994 to 1999

Canadian Journal of Cardiology

Volumn 20, Issue 2, 2004, Pages 213-219

  Quan, Hude ^a   Cujec, Bibiana ^b   Jin, Yan ^c   Johnson, David ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Research and Evidence   (Canada)

Author keywords

Acute myocardial infarction; Alberta; Mortality; Trend

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CANADA; CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; FATALITY; FEMALE; HEALTH CARE COST; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALBERTA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 1642444998     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Smith DW. Changing causes of death of elderly people in the United States, 1950-1990. Gerontology 1998;44:331-5.
2. Anderson RN. Deaths: Leading causes for 1999. Natl Vital Star Rep 2001;49:1-87.
3. Stein J. Fact sheet: Major causes of death in Canada, 1993-1995. Chron Dis Can 1997;18:91-2.
4. Brophy JM. The epidemiology of acute myocardial infarction and ischemic heart disease in Canada: Data from 1976 to 1991. Can J Cardiol 1997;13:474-8.
5. Saito I, Ozawa H, Aono H, Ikebe T, Yamashita T, Makino Y. Trends in fatal coronary heart disease among people aged 25-74 years in Oita City, Japan, from 1987-1998. J Clin Epidemiol 2002;55:469-76.
6. The Nova Scotia-Saskatchewan Cardiovascular Disease Epidemiology Group. Trends in incidence and mortality from acute myocardial infarction in Nova Scotia and Saskatchewan 1974 to 1985. Can J Cardiol 1992;8:253-8.
7. Gregor RD, Bata IR, Brownell B, Wolf HK. Trends in the in-hospital treatment of acute myocardial infarction between 1984 and 1993: The Halifax County MONICA Project. Can J Cardiol 2000;16:596-603.
8. Bata IR, Gregor RD, Eastwood BJ, Wolf HK. Trends in the incidence of acute myocardial infarction between 1984 and 1993 - The Halifax County MONICA Project. Can J Cardiol 2000;16:589-95.
9. Salomaa V, Rosamond W, Mahonen M. Decreasing mortality from acute myocardial infarction: Effect of incidence and prognosis. J Cardiovasc Risk 1999;6:69-75.
10. Keil U, Liese AD, Hense HW, et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring trends and determinants in cardiovascular diseases. Eur Heart J 1998;19:1197-207.
11. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
12. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277:115-21.
13. Alter DA, Naylor CD, Austin PC, Tu JV. Long-term MI outcomes at hospitals with or without on-site revascularization. JAMA 2001;285:2101-8.
14. Barakat K, Wilkinson P, Suliman A, Ranjadayalan K, Timmis A. Changing face of acute myocardial infarction in east London: A prospective cohort study of trends in management and outcome in the reperfusion era. J Cardiovasc Risk 2001;8:21-9.
15. Le Feuvre CA, Connolly SJ, Cairns JA, Gent M, Roberts RS. Comparison of mortality from acute myocardial infarction between 1979 and 1992 in a geographically defined stable population. Am J Cardiol 1996;78:1345-9.
16. Gheorghiade M, Ruzumna P, Borzak S, Havstad S, Ali A, Goldstein S. Decline in the rate of hospital mortality from acute myocardial infarction: Impact of changing management strategies. Am Heart J 1996;131:250-6.
17. Naylor CD, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: The Ontario experience, 1981 to 1991. J Am Coll Cardiol 1994;24:1431-8.
18. Tsuyuki RT, Teo KK, Ikuta RM, Bay KS, Greenwood PV, Montague TJ. Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987-92. Relative importance of age, sex, and medical therapy. Chest 1994;105:1687-92.
19. Bata IR, Eastwood BJ, Gregor RD, et al. Decreasing mortality from acute myocardial infarctions: Effect of attack rates and case severity. J Clin Epidemiol 1997;50:787-91.
20. Montague TJ, Wong RY, Burton JR, Bay KS, Catellier DJ, Teo KK. Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90. Can J Cardiol 1992;8:596-600.
21. International Classification of Diseases, 9th Revision, Clinical Modification (ICD9-CM). PMIC, 2001.
22. Alberta Health. Alberta Health Statistical Supplement 1995-96. Edmonton: Alberta Health Care Insurance Plan, 1997.
23. Funding Health Resource Branch. Regional Health Authority Global Funding Manual, 2000-01. Edmonton: Alberta Health and Wellness, 2002.
24. Canadian Institute for Health Information. Guidelines for Management Information Systems in Canadian Health Service Organizations. Ottawa: Canadian Institute for Health Information, 1999.
25. McKillop I, Pink GH, Johnson LM. The financial management of acute care in Canada: A review of funding, performance monitoring and reporting practices. Ottawa: Canadian Institute for Health Information, 2001.
26. Alberta Health Care Insurance Plan. Schedule of Medical Benefits. Edmonton: Alberta Health and Wellness, 1998.
27. Health Surveillance, Alberta Health and Wellness, 2001 Mortality rates for Alberta and its health regions: 1986-1999, Epidemiological measures database. Edmonton: Alberta Health and Wellness, 2001.
28. Pilote L, Lavoie F, Ho V, Eisenberg MJ. Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995, CMAJ 2000;163:31-6.
29. Tu JV, Naylor CD, Austin P. Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ 1999;161:1257-61.
30. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Blackburn H, Luepker RV. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996;334:884-90.
31. McGovern PG, Jacobs DRJ, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: The Minnesota heart survey. Circulation 2001;104:19-24.
32. O'Hara D, McDonald I. Trends in in-hospital mortality following acute myocardial infarction (AMI) in Victoria, 1987-1994. Austral NZ J Med 1997;27:431-6.
33. Tyden P, Hansen O, Janzon L. Intra-urban variations in incidence and mortality in myocardial infarction. A study from the myocardial infarction register in the city of Malmo, Sweden. Eur Heart J 1998;19:1795-801.
34. Luepker RV, Herlitz J. Differences in the treatment of acute myocardial infarction between regions of countries and the impact on prognosis. J Cardiovasc Risk 1999;6:77-87.
35. Heidenreich PA, McClellan M. Trends in treatment and outcomes for acute myocardial infarction: 1975-1995. Am J Med 2001;110:165-74.
36. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence. Am Heart J 2003;145:438-44.
37. Rodrigues EJ, Simpson E, Richard H, Pilote L. Regional variation in the management of acute myocardial infarction in the province of Quebec. Can J Cardiol 2002;18:1067-76.
38. Pilote L, Califf RM, Sapp S, et al. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med 1995;333:565-72.
39. Montague T, Taylor L, Martin S, et al. Can practice patterns and outcomes be successfully altered? Examples from cardiovascular medicine. The Clinical Quality Improvement Network (CQIN) Investigators. Can J Cardiol 1995;11:487-92.
40. Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 2002;40:675-85.
41. Romano PS, Roos LL, Luft HS, Jollis JG, Doliszny K. A comparison of administrative versus clinical data: Coronary artery bypass Surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. J Clin Epidemiol 1994;47:249-60.
42. Rawson NS, Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med 1995;14:2627-43.
43. Mahonen M, Salomaa V, Torppa J, et al. The validity of the routine mortality statistics on coronary heart disease in Finland: Comparison with the FINMONICA MI register data for the years 1983-1992. Finnish multinational MONitoring of trends and determinants in CArdiovascular disease. J Clin Epidemiol 1999;52:157-66.
44. Iezzoni LI, Burnside S, Sickles L, Moskowitz MA, Sawitz E, Levine PA. Coding of acute myocardial infarction. Clinical and policy implications. Ann Intern Med 1988;109:745-51.
45. Pladevall M, Goff DC, Nichaman MZ, et al. An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project. Int J Epidemiol 1996;25:948-52.
46. Heyland DK, Lavery JV, Tranmer J, Shoett SED, Taylor SJ, for the Queen's/KGH End of Life Research Group. Dying in Canada: Is it an institutionalized, technologically supported experience? J Palliat Care 2000;16:S10-6.